Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

DNA Methylation in Adenocarcinoma of the Prostate: Analysis of Validated Biomarkers in Urine

NCT06347809 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT06347809
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06347809 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
DNA Methylation in Adenocarcinoma of the Prostate: Analysis of Validated Biomarkers in Urine
Lead sponsor
Mayo Clinic
Phase
Observational
Overall status
Terminated
Start date
January 23, 2019
Completion date
July 31, 2025
Enrollment
24 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate adenocarcinoma, prostate carcinoma